Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1999-05-11
2000-07-04
Elliott, George C.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
536 221, 536 231, 536 256, 435 911, C07H 2102, C07H 2104, C12P 1934
Patent
active
06083482&
ABSTRACT:
Conformationally restricted 3',5'-bridged nucleoside analogues are described herein. The compounds can be prepared by cyclization at C3' and C5' of nucleosides through a linker or linking molecule. The nucleoside bases may be modified or unmodified. The nucleosides can be used as oligonucleotide building blocks or as small molecule pharmaceutical ingredients.
REFERENCES:
Guangyi Wang, Conformationally locked nucleosides. Synthesis and stereochemical assignments of 3'-N,5'-C-bridged 3'-amino-3'-deoxythymidines. Tetrahedron Letters 40 (1999), pp. 6343-6346, Oct. 1999.
Elliott George C.
Epps Janet L.
Fish Robert D.
ICN Pharmaceuticals, Inc.
LandOfFree
Conformationally locked nucleosides and oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conformationally locked nucleosides and oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conformationally locked nucleosides and oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1483247